UPDATE: Morgan Stanley Reiterates On Eli Lilly & Co. On Lackluster Survival Benefit
June 02, 2014 at 09:17 AM EDT
In a report published Monday, Morgan Stanley analyst David Risinger reiterated an Underweight rating on Eli Lilly & Co. (NYSE: LLY), but ...
